Food Grade Fumaric Acid Market Size Overview, Top Companies, Inventive Trends and Forecast to 2037 – Jewish Life News

With having published myriads of reports, Food Grade Fumaric Acid Market Research imparts its stalwartness to clients existing all over the globe. Our dedicated team of experts deliver reports with accurate data extracted from trusted sources. We ride the wave of digitalization facilitate clients with the changing trends in various industries, regions and consumers. As customer satisfaction is our top priority, our analysts are available 24/7 to provide tailored business solutions to the clients.

In this new business intelligence report, Food Grade Fumaric Acid Market Research serves a platter of market forecast, structure, potential, and socioeconomic impacts associated with the global Food Grade Fumaric Acid market. With Porters Five Forces and DROT analyses, the research study incorporates a comprehensive evaluation of the positive and negative factors, as well as the opportunities regarding the Food Grade Fumaric Acid market.

Request Sample Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2558169&source=atm

The Food Grade Fumaric Acid market report has been fragmented into important regions that showcase worthwhile growth to the vendors Region 1 (Country 1, Country 2), region 2 (Country 1, Country 2) and region 3 (Country 1, Country 2). Each geographic segment has been assessed based on supply-demand status, distribution, and pricing. Further, the study provides information about the local distributors with which the market players could create collaborations in a bid to sustain production footprint.

The following manufacturers are covered in this report:Bartek IngredientsPolynt GroupThirumalai ChemicalIsegenFuso ChemicalsNippon ShokubaiYantai Hengyuan BioengineeringJiangsu Jiecheng BioengineeringChangzhou Yabang ChemicalAnhui Sealong BiotechnologyChangmao Biochemical EngineeringSuzhou Youhe Science and TechnologyZhejiang Dongda Biological TechnologyChina Blue Star Harbin PetrochemicalJiangsu Suhua GroupJiaoda Rising Weinan ChemicalChina BBCA Group

Food Grade Fumaric Acid Breakdown Data by TypePurity: 99.5%Others

Food Grade Fumaric Acid Breakdown Data by ApplicationAlcoholic BeveragesSoft DrinkBakery FoodSnacks and ConfectioneryDairy and Frozen DessertsOthers

Food Grade Fumaric Acid Production Breakdown Data by RegionNorth AmericaEuropeChinaJapan

Food Grade Fumaric Acid Consumption Breakdown Data by RegionNorth AmericaUnited StatesCanadaMexicoEuropeGermanyFranceUKItalyRussiaAsia-PacificChinaJapanSouth KoreaIndiaAustraliaIndonesiaThailandMalaysiaPhilippinesVietnamCentral & South AmericaBrazilMiddle East & AfricaTurkeyGCC CountriesEgyptSouth Africa

The study objectives are:To analyze and research the global Food Grade Fumaric Acid capacity, production, value, consumption, status and forecast;To focus on the key Food Grade Fumaric Acid manufacturers and study the capacity, production, value, market share and development plans in next few years.To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.To define, describe and forecast the market by type, application and region.To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.To identify significant trends and factors driving or inhibiting the market growth.To analyze the opportunities in the market for stakeholders by identifying the high growth segments.To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Food Grade Fumaric Acid :History Year: 2014-2018Base Year: 2018Estimated Year: 2019Forecast Year 2019 to 2025For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Make An EnquiryAbout This Report @ https://www.marketresearchhub.com/enquiry.php?type=E&repid=2558169&source=atm

What does the Food Grade Fumaric Acid market report contain?

Readers can get the answers of the following questions while going through the Food Grade Fumaric Acid market report:

And many more

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2558169&licType=S&source=atm

For More Information Kindly Contact:

marketresearchhub.com

90 State Street,

Albany NY,

United States 12207

Tel: +1-518-621-2074

USA-Canada Toll Free: 866-997-4948

Email: [emailprotected]

See the rest here:
Food Grade Fumaric Acid Market Size Overview, Top Companies, Inventive Trends and Forecast to 2037 - Jewish Life News

Design Indaba 2020: A commitment to changing the world, for good – Daily Maverick

Sho Madjozi (Image courtesy of the Design Indaba)

Take the case of Mazbahul Islam, an inspirational millennial from Bangladesh. A business school graduate, who grew up in the high-rises of Dhakka, he started working in user interface and user experience (UI/UX) on graduation, when one of his business school cohorts, Rafi Islam, called him one day. Islams uncle had taken ill in a small, rural village and his brother (Islams father), had used the only transport available to get him to the nearest medical facility 20km away on rough roads.

The transport is an open, flat-bed rickshaw/tricycle structure and his uncle died en route. The four graduates came together to form a start-up: They created an emergency service, fit for its environment, using traditional transport from adapted tuk-tuks, or tricycles. Each tricycle is equipped with medical emergency facilities, buoyed by robust shock-absorbers, and this has created a career path for rural ambulance drivers and paramedics.

And if you thought this was cool, wait for the astonishingly accessible renowned scientist, Indian-born, MIT-trained Bioengineering Professor from Stanford University, Manu Prakash, who is also a MacArthur Fellow. A crowd favourite, quiet-spoken and humble, and deeply committed to his work across the world from India to Madagascar Prakash has made science accessible, affordable for all and participative.

After noticing an electric centrifuge being used as a doorstop in Uganda where there is no power, Prakash returned to the laboratory and, experimenting with childrens toys, like yoyos, he devised an inexpensive rotating mechanism, the Paperfuge, based on button and string tools that date back to Ancient Greece, and appear to be present in every culture. This centrifuge, which is essential in medical diagnosis from blood and stool samples, runs at 125,000rpm, which is equal to 30,000 G Forces per atom. Underlining his thinking, he noted: It is not about developing and developed worlds, but the haves and have-nots: Of 2 billion children in the world, 1 billion go to schools without walls; 1 billion people have to walk twelve hours to access healthcare!

But Prakashs most popular invention has to be his microscopy project a hit across the world. An origami-like fold-up paper unit, the Foldscope has turned communities into contributing scientists in the most inaccessible parts of the globe, at $1.75 per unit: Of 3,500 mosquito species, only 40 carry the deadliest disease in the world. But you can only measure them in 575 locations in Africa. These are the places where entomologists, not mosquitoes, live.

Having built a community of one million contributing scientists across the world, in the most remote parts of the globe, he notes that the future of science will not be written by academics but by people who are the first in their generation to experience science. Adding fun to the science, he noted: Mosquitoes use their wings to produce sound now available for download as a ringtone.

From South Africa hails Vukheta Mukhari, a masters candidate in civil engineering at the University of Cape Town, who, with his team is working on making the worlds first bio-brick from urine.

Working with brick, mortar and concrete mega-structures is Ghanaian-born artist, Ibrahim Mahama. Already an acclaimed visual artist, it has been his mission to create significant art that spoke of his roots jute bag roots and colonisation.

Having created a sensation at key sites and major art exhibitions of the world, where he covered buildings (Christo-like) with jute bags, telling a powerful message of colonial return, (from the Venice Biennale, to Cape Town where he was commissioned to create an installation, Labour of Many, for the Norval Foundation in 2019), he has focused on his homeland, and his home-town of Tamale. He not only replicated the work, but began creating (and resurrecting colonial), structures that can be used as areas of production and learning, between.

Ghana, the home of cocoa, colonised by Britain, is filled with abandoned relics of colonialism: railway sidings, grain silos, industrial warehouses, being reclaimed by vegetation, and sometimes, the people, as well as aeroplanes. One of his most whimsically audacious projects was to uproot abandoned aeroplanes dating back a century, and transporting them to his home town in the north where he has created a centre of learning by turning the aeroplanes into classrooms.

His philosophy is wry: Turn colonialism on its head. For the Manchester International Festival in 2019, he took all the elements of abandoned railway carriages seats and rails and shipped them back to England, and reconstructed a Parliament of Ghosts. He has now taken the abandoned and reconstructed relics of colonialism back to Ghana, to create a vibrant peoples parliament in Tamale.

Working with history, reconstructing, deconstructing and resurrecting for meaningful production, his mission is to work in-field, with what is there. Of the humble jute bag that has wrapped mammoth theatres and palaces in both the global North and Ghana, he notes: I used jute sacks because for me, the history of crisis and failure is absorbed into the material. Their history speaks of how global transactions and capitalist structures work. And because how their humbleness contrasts with the monumentality of the buildings they cover.

Reworking her Tsonga roots in fabrics as well is local music sensation Sho Madjozi, (Maya Christinah Xichavo Wegerif), who kicked the festival off with a show-piece psychedelic, Afro-futurist style, interwoven with a powerful narrative; she talked about history, colonisation, tradition and her contemporised reworking of her Tsonga culture. She traced back the history of the Xibelani dance and the potential origins of the Tinguvu skirt, and shared her dream to regularly stage a massive Xibelani Festival in Giyani to celebrate her heritage, upscaled and revived for global consumption in technicolour, rap and gqom.

When the Design Indaba moved from the Cape Town International Convention Centre to the Artscape Theatre some years back, the intention was to ramp up the spectacle with theatrical technologies. LGBTQI+ fashion activist Sunny Dolat from Kenya not only shared his clothing design philosophy, but performed a beautiful piece using massive drapes from white muslin, lowered from the trusses into vast vats, and then receding to the rafters with red dye dripping downwards, as Dolat too, in his beautifully tailored white kaftan, immersed himself in the red liquid and emerged dripping.

The most profound and resonant performance was by South African actor, Nhlanhla Mahlangu, who has collaborated with the South-African born global luminaries of our artistic practice (William Kentridge, Robyn Orlin, Gregory Vuyani Maqoma and Hugh Masekela), and found time to complete his Masters of Arts in Creative Research.

Taking the audience back to his youth, Mahlangu performed in loincloth, accompanied by an absurdist old vacuum cleaner as a key prop, and so poignantly brought home the realities of apartheid South Africa in the 1980s: the sadistic decimation of human and animal lives by the brutal apartheid police machinery. He poetically reminisced about accompanying his grandmother to work and bonding with Penny, the pet dog of her white employers.

When the employers migrated, his granny was turfed out and became a street trader. Penny joined them in the tin shack in Phola Park and ate better than Nhlanhla did, but also wandered around the informal settlement; and Penny produced little Pennies and little grand-Pennies, until one night the police arrived. The people fled; the houses and animals were left behind; the shacks burnt to the ground. They returned to reclaim smouldering ashes and corpses. Chant, the first of his works on the chant theme is a piece that should be compulsory for all South Africans. It drives home so much of what has been forgotten in the reconciliation and bonhomie of the 90s, and the millennial hate-speech that remains disembodied from the realities of the apartheid and post-apartheid state. Our hearts broke for thousands of Pennies and Nhlanhlas across our land.

At this years festival, Impact seemed to be the buzz word, as were design thinking, collaboration, customer journey and user-centred design. But not just buzz-words or coda for design practise; the exploratory Rape Kit was another innovation by a young masters graduate, Antya Waegemann, who managed to deconstruct over 20 unintelligible and alienating steps administered by professionals, to rape victims, survivors under forensic examination, into a kit that works with the emotional and medical needs of the survivor showing us how such user-centred work can radically transform such experiences in the most intimate way. The kit is being prototyped for Silicon Valley funding.

The most uplifting and humorous collaboration was about four friends, sitting in a pub. It sounds like a bad joke, which it was for some. Utterly disheartened by the Brexit inequity, they started a movement; calling themselves Led By Donkeys, the four men decided to replicate offensive twitter posts by offensive politicians in billboard format and plastered these on billboards across the UK in the dead of night. The movement spread and evolved into massive flags during protests, beach sculpture and finally, a projection on the White Cliffs of Dover, imploring the EU to retain the British star from the EU symbol for safekeeping until Britain returns.

When collaboration, inclusion and community come together across academic disciplines, impact happens, and provides a key to global advance and innovation. It was the designers collaborating with scientists, who left the audience gaping at the possibilities of nano- and bio-technology. While one speaker focused on the bacteria inhabiting our bodies, two others examined the organic structure of both colour and fabric. Bio-designer, synthetic biologist and academic, Natsai Audrey Chieza, a D&AD prize winner, hailing originally from Zimbabwe, is obsessed with the structure of bio-friendly pigmentation.

Chiezas work with chemists, engineers and scientists, is forging multidisciplinary innovation in both practice, and academic research. She shared how the parameter-defined discipline of science, when fused with the beyond-constraint disciplinary practice of design, allowed her to interrogate an organic pigment option; the idea was to prove that progress requires true collaboration, while posing the question: Why are designers not upstream in the invention and innovation process, if our scientists are designing for real-world application?

Fashion technologist Elissa Brunato, set the collective guilt festering in the audience with her deconstruction of the life cycle of the sparkling sequin, hoping to disrupt the industry and return it to a bio-friendly model. Sequins are made from plastic, which derives from petrol, and are one of those nano-pollutants that are clogging up our landfills, oceans and planet. She, and Natsai, are fusing design with biomimicry: using collagen, she has created her first prototype bio-iridescent sequins.

Another young graduate using biomimicry, Catalinao Loatero, hailing from Columbia is prototyping trees and leaves to create energy. Troubled by the social devastation wrought on rural, indigenous peoples deprived of electricity, infrastructure and services by her government, she set about researching an alternative energy option within the structure of leaves, which create an internal energy. Her prototype mimics, and extends, the shape and function of leaves to produce an innovative bio-friendly green energy.

The algorithm geniuses were represented by the Head of Google Creative Lab, Robert Wong, whose tears and joy showed what massive corporates in the cloud can do to change the world for good.

Graphic designer Olimpia Zagnoli, with her whimsical designs not only shared her passion for colour, but her quiet activism. I grew up in the 80s, when young girls were given pink Barbies, pink everything. It was not fair especially to the colour pink! An activist for colour, she describes the uniform use of beige, forest-green and Scandi-grey for furniture. But her difference came in work for Barilla the pasta producers: One of their directors was outed in Italy for his proclamation that being gay was antithetical to the traditional notion of the Italian family. At first, reluctant to design for the apologetic organisation, her iconic packaging for their new range of spaghetti graphically depicts a gorgeously bright lesbian couple embracing a plate of Barilla pasta.

Chinese architects Neri and Hu presented their iconic buildings, as did Chicago-based mega-structure architect, Jeanne Gang, whose passion for bio-diversity is incorporated into her high-rise buildings, conceptually and physically. Based on Cyril Ramaphosas 2020 State of the Nation address this year, she publicly committed to building a local biodiversity centre in South Africa in the future. British architect Paul Cocksedge has already commenced his project for a bridge over the Liesbeeck river in Cape Town.

As the 25th edition of Design Indaba ends, its easy to see how the scores of scientists, collaborators, designers, innovators and the 600 speaker graduates who have graced the festival over the past years have brought not only novelty and audacity, but also change and impact. And hope for a better tomorrow. ML

Please note you must be a Maverick Insider to comment. Sign up here or if you are already an Insider.

Read more from the original source:
Design Indaba 2020: A commitment to changing the world, for good - Daily Maverick

Global Bioreactors and Fermenters Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 – Jewish Life News

ORBIS RESEARCH has recently announced Global Bioreactors and Fermenters Market report with all the critical analysis on current state of industry, demand for product, environment for investment and existing competition. Global Bioreactors and Fermenters Market report is a focused study on various market affecting factors and comprehensive survey of industry covering major aspects like product types, various applications, top regions, growth analysis, market potential, challenges for investor, opportunity assessments, major drivers and key players (The major players covered in Bioreactors and Fermenters are: Sartorius AG (BBI), ZETA, Danaher (Pall), Thermo Fisher, Pierre Guerin (DCI-Biolafitte), Merck KGaA, Bioengineering AG, Praj Hipurity Systems, Eppendorf AG, Applikon Biotechnology, Infors HT, Solaris, etc. )

Description

The Bioreactors and Fermenters market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Request a sample of this report @ https://www.orbisresearch.com/contacts/request-sample/4168186

Global Bioreactors and Fermenters Market the Major Players Covered in Bioreactors and Fermenters are: The major players covered in Bioreactors and Fermenters are: Sartorius AG (BBI), ZETA, Danaher (Pall), Thermo Fisher, Pierre Guerin (DCI-Biolafitte), Merck KGaA, Bioengineering AG, Praj Hipurity Systems, Eppendorf AG, Applikon Biotechnology, Infors HT, Solaris, etc. Among other players domestic and global, Bioreactors and Fermenters market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Global Bioreactors and Fermenters Market segmentation

Bioreactors and Fermenters market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Bioreactors and Fermenters market has been segmented into Single-use Bioreactors, Multiple-use Bioreactors, etc.

By Application, Bioreactors and Fermenters has been segmented into CROs, Academic and Research Institutes, Others, etc.

Browse the complete report @ https://www.orbisresearch.com/reports/index/global-bioreactors-and-fermenters-market-2020-by-manufacturers-regions-type-and-application-forecast-to-2025

Global Bioreactors and Fermenters Market Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Bioreactors and Fermenters market presented in the report. This section sheds light on the sales growth of different regional and country-level Bioreactors and Fermenters markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Bioreactors and Fermenters market.

The report offers in-depth assessment of the growth and other aspects of the Bioreactors and Fermenters market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Bioreactors and Fermenters markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.

Bioreactors and Fermenters competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Bioreactors and Fermenters sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Bioreactors and Fermenters sales, revenue and market share for each player covered in this report.

Make an enquiry of this report @ https://www.orbisresearch.com/contacts/enquiry-before-buying/4168186

Table of Contents

1 Bioreactors and Fermenters Market Overview1.1 Product Overview and Scope of Bioreactors and Fermenters1.2 Classification of Bioreactors and Fermenters by Type1.2.1 Global Bioreactors and Fermenters Revenue by Type: 2015 VS 2019 VS 20251.2.2 Global Bioreactors and Fermenters Revenue Market Share by Type in 20191.2.3 OTC Interest Rate Derivatives1.2.4 OTC Forex Derivatives1.2.5 Others1.3 Global Bioreactors and Fermenters Market by Application1.3.1 Overview: Global Bioreactors and Fermenters Revenue by Application: 2015 VS 2019 VS 20251.3.2 OTC Options1.3.3 Forward1.3.4 SWAP1.3.5 Others1.4 Global Bioreactors and Fermenters Market by Regions1.4.1 Global Bioreactors and Fermenters Market Size by Regions: 2015 VS 2019 VS 20251.4.2 Global Market Size of Bioreactors and Fermenters (2015-2025)1.4.3 North America (USA, Canada and Mexico) Bioreactors and Fermenters Status and Prospect (2015-2025)1.4.4 Europe (Germany, France, UK, Russia and Italy) Bioreactors and Fermenters Status and Prospect (2015-2025)1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bioreactors and Fermenters Status and Prospect (2015-2025)1.4.6 South America (Brazil, Argentina, Colombia) Bioreactors and Fermenters Status and Prospect (2015-2025)1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bioreactors and Fermenters Status and Prospect (2015-2025)

2 Company Profiles2.1 GF Securities2.1.1 GF Securities Details2.1.2 GF Securities Major Business and Total Revenue (Financial Highlights) Analysis2.1.3 GF Securities SWOT Analysis2.1.4 GF Securities Product and Services2.1.5 GF Securities Bioreactors and Fermenters Revenue, Gross Margin and Market Share (2018-2019)2.2 SHANXI Securities2.2.1 SHANXI Securities Details2.2.2 SHANXI Securities Major Business and Total Revenue (Financial Highlights) Analysis2.2.3 SHANXI Securities SWOT Analysis2.2.4 SHANXI Securities Product and Services2.2.5 SHANXI Securities Bioreactors and Fermenters Revenue, Gross Margin and Market Share (2018-2019)2.3 GUOTAI JUNAN Securities2.3.1 GUOTAI JUNAN Securities Details2.3.2 GUOTAI JUNAN Securities Major Business and Total Revenue (Financial Highlights) Analysis2.3.3 GUOTAI JUNAN Securities SWOT Analysis2.3.4 GUOTAI JUNAN Securities Product and Services2.3.5 GUOTAI JUNAN Securities Bioreactors and Fermenters Revenue, Gross Margin and Market Share (2018-2019)2.4 ZHONGTAI Securities2.4.1 ZHONGTAI Securities Details2.4.2 ZHONGTAI Securities Major Business and Total Revenue (Financial Highlights) Analysis2.4.3 ZHONGTAI Securities SWOT Analysis2.4.4 ZHONGTAI Securities Product and Services2.4.5 ZHONGTAI Securities Bioreactors and Fermenters Revenue, Gross Margin and Market Share (2018-2019)2.5 INDUSTRIAL Securities

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:Hector CostelloSenior Manager Client Engagements4144N Central Expressway,Suite 600, Dallas,Texas 75204, U.S.A.Phone No.: USA: +1 (972)-362-8199 | IND: +91 895 659 5155Email ID: [emailprotected]

Read this article:
Global Bioreactors and Fermenters Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 - Jewish Life News

Hagerstown Hall has free pads and tampons. Students want other UMD dorms to follow suit. – The Diamondback

By Luciana Perez-Uribe and Eric Neugeboren

Staff writers

When Deesha Ajmera moved into the University of Marylands Hagerstown Hall last fall, she wasnt expecting its bathrooms to offer free pads and tampons.

Then, in December, the dorms resident assistants dipped into their event funding to stock every bathroom with free sanitary products. Now, Ajmera wants such a program to become commonplace across the universitys dorms.

I personally wouldnt have thought of it, which is sad, the freshman bioengineering major said. Its a necessity, and its something that we cant live without.

Ajmera is far from alone in her support for the program in two weeks, over 450 people have signed a petition calling for all dorms on campus to offer free period products.

Doing so would be an opportunity to meet the needs of the universitys diverse student body, said Hagerstown resident assistant Liam McCammon, who started the petition.

We have a lot of different types of students. People come from a lot of different backgrounds and have a lot of different needs, including financial needs, said McCammon, a sophomore economics major.

Kush Kharod, another Hagerstown resident assistant, first thought up the Period Poverty Program. Kharod collaborated with other resident assistants, residents and the Department of Resident Life to get it started.

These efforts build upon a previous push by students to make sanitary products more accessible on the campus. Currently, free pads and tampons are offered in select locations on campus, including the University Health Center and Stamp Student Union.

Last fall, five students requested $18,000 from the Student Facilities Fund to stock 15 of the universitys most highly-trafficked bathrooms with period products for a year. While their request was approved by the committee in charge of the fund last semester, it is still waiting on a greenlight from the Facilities Council.

[Read more:Few UMD bathrooms offer free tampons and pads. These students want to change that.]

And in the last 10 days of the fall semester when Hagerstowns bathrooms started offering free period products a total of 20 pads were used, Kharod wrote in a message. Tampons were added to the bathrooms earlier this month, and in the first two weeks, 80 have been used.

Next, McCammon said the halls staff is aiming to expand the program to the two other dorms in the Ellicott Community. They eventually hope the program will be expanded to every dorm on campus.

Ajmera hopes free pads and tampons are one day offered in every building on campus.

If you just randomly get your period, youre kind of screwed, she said. Its really helpful, knowing that its there if you need it.

Maura Johnston, a freshman psychology major who lives in Hagerstown Hall, joined Ajmera in signing the petition. While she has enough money to buy her own period products, thats a privilege she recognizes that others may not have.

[Read more:After years of lobbying from residents, Calvert Hills will soon have a new drainage system]

I know that there are many girls that get their period that it is a huge finance for them and theyre unable to have their own supply, she said.

Nistha Mitra, another Hagerstown resident assistant and an international student representative for the Student Government Association, said she aims to introduce a bill to the body in the upcoming weeks, supporting the dorms Period Poverty program.

Mitra said she hopes the bill will help students become more aware of the initiative, eventually helping it to fexpand to more campus dorms. She stressed she was speaking in her role as a resident assistant, and not as an SGA representative.

Its a very natural thing and [sanitary products] should be very easily available to everyone, irrespective of their socioeconomic status, Mitra said.

Here is the original post:
Hagerstown Hall has free pads and tampons. Students want other UMD dorms to follow suit. - The Diamondback

Hybrid microscope could bring digital biopsy to the… – ScienceBlog.com

By adding infrared capability to the ubiquitous, standard optical microscope, researchers at the University of Illinois at Urbana-Champaign hope to bring cancer diagnosis into the digital era.

Pairing infrared measurements with high-resolution optical images and machine learning algorithms, the researchers created digital biopsies that closely correlated with traditional pathology techniques and also outperformed state-of-the-art infrared microscopes.

Led byRohit Bhargava, a professor of bioengineering and the director of theCancer Center at Illinois, the group published itsresultsin the Proceedings of the National Academy of Sciences.

Professor Rohit Bhargava led the research team.

Photo by L. Brian Stauffer

The advantage is that no stains are required, and both the organization of cells and their chemistry can be measured. Measuring the chemistry of tumor cells and their microenvironment can lead to better cancer diagnoses and better understanding of the disease, Bhargava said.

The gold standard of tissue pathology is to add dyes or stains so that pathologists can see the shapes and patterns of the cells under a microscope. However, it can be difficult to distinguish cancer from healthy tissue or to pinpoint the boundaries of a tumor, and in many cases diagnosis is subjective.

For more than a century, we have relied on adding dyes to human tissue biopsies to diagnose tumors. However, the shape and color induced by the dye provide very limited information about the underlying molecular changes that drive cancer, Bhargava said.

Technologies like infrared microscopy can measure the molecular composition of tissue, providing quantitative measures that can distinguish cell types. Unfortunately, infrared microscopes are expensive and the samples require special preparation and handling, making them impractical for the vast majority of clinical and research settings.

Machine-learning tools can analyze the data from the infrared-optical hybrid microscope to create digital versions of standard dyes, left, or to identify tissue types based on their chemical composition, right.

Images courtesy of Rohit Bhargava

Bhargavas group developed its hybrid microscope by adding an infrared laser and a specialized microscope lens, called an interference objective, to an optical camera. The infrared-optical hybrid measures both infrared data and a high-resolution optical image with a light microscope the kind ubiquitous in clinics and labs.

We built the hybrid microscope from off-the-shelf components. This is important because it allows others to easily build their own microscope or upgrade an existing microscope, said Martin Schnell, a postdoctoral fellow in Bhargavas group and first author of the paper.

Combining the two techniques harnesses the strengths of both, the researchers said. It has the high resolution, large field-of-view and accessibility of an optical microscope. Furthermore, infrared data can be analyzed computationally, without adding any dyes or stains that can damage tissues. Software can recreate different stains or even overlap them to create a more complete, all-digital picture of whats in the tissue.

This side-by-side comparison of a breast tissue biopsy demonstrates some of the infrared-optical hybrid microscopes capabilities. On the left, a tissue sample dyed by traditional methods. Center, a computed stain created from infrared-optical hybrid imaging. Right, tissue types identified with infrared data. The pink in this image signifies malignant cancer.

Images courtesy of Rohit Bhargava

The researchers verified their microscope by imaging breast tissue samples, both healthy and cancerous, and comparing the results of the hybrid microscopes computed dyes with those from the traditional staining technique. The digital biopsy closely correlated with the traditional one.

Furthermore, the researchers found that their infrared-optical hybrid outperformed state-of-the-art in infrared microscopes in several ways: It has 10 times larger coverage, greater consistency and four times higher resolution, allowing infrared imaging of larger samples, in less time, with unprecedented detail.

Infrared-optical hybrid microscopy is widely compatible with conventional microscopy in biomedical applications, Schnell said. We combine the ease of use and universal availability of optical microscopy with the wide palette of infrared molecular contrast and machine learning. And by doing so, we hope to change how we routinely handle, image and understand microscopic tissue structure.

The researchers plan to continue refining the computational tools used to analyze the hybrid images. They are working to optimize machine-learning programs that can measure multiple infrared wavelengths, creating images that readily distinguish between multiple cell types, and integrate that data with the detailed optical images to precisely map cancer within a sample. They also plan to explore further applications for hybrid microscope imaging, such as forensics, polymer science and other biomedical applications.

It is very intriguing what this additional detail can offer in terms of pathology diagnoses, Bhargava said. This could help speed up the wait for results, reduce costs of reagents and people to stain tissue, and provide an all-digital solution for cancer pathology.

The National Institutes of Health supported this work. Bhargava is affiliated with theBeckman Institute for Advanced Science and Technologyand theCarle Illinois College of Medicine.

Read the rest here:
Hybrid microscope could bring digital biopsy to the... - ScienceBlog.com

Viewpoints: Medicaid Expansion Reveals How Liberal Policies Make For Good Politics; Hey, Congress, What’s The Hold Up With Surprise Medical Bills? -…

Opinion writers tackle these and other health issues.

The New York Times:Progressives Are The Real PragmatistsWhen left-wing Democrats push for universal benefits and expansive new policies, they do so with a theory of politics in mind. It goes like this: The reason to fight for debt-free college or Medicare for all isnt just to improve life for Americans, but to build new ground for progressive political activity. New programs create new constituencies, and new programs with broad benefits can give more Americans a stake in the expansion and preservation of the welfare state. Conservatives know this. Thats why theyve fought so hard to block or undermine even modest new programs. (Jamelle Bouie, 1/13)

The Washington Post:Congress Needs To Settle Its Differences And Put An End To Surprise Medical BillingWashington seemed to be working, for once. Last month, key members of the House and Senate House Energy and Commerce Committee Chairman Frank Pallone Jr. (D-N.J.), Rep. Greg Walden (R-Ore.), Senate Health Committee Chairman Lamar Alexander (R-Tenn.) and Sen. Patty Murray (D-Wash.) had negotiated legislation that would end so-called surprise medical billing. Example: when you have emergency surgery, then get slammed unexpectedly with a huge bill from an out-of-network anesthesiologist you didnt choose. The legislation was set to be included last month in a must-pass funding bill. (1/12)

Cleveland Plain Dealer:There Is No Excuse For Surprise Medical Billing. Ohio Should Act.Voters concerned about surprise billing should let those legislators know of their concerns, and share any personal experiences with surprise billing that theyve had. According to a report by the Commonwealth Fund (a philanthropy founded by the Harkness family, which had Cleveland ties), as of July, 28 states had enacted measures to protect patients against surprise medical billing.Ohio should do the same. (1/10)

The Hill:Where Women's Health Care Is Lacking, Women Are DyingA woman is more likely to die of cervical cancer in Alabama than in any other state in the country. An African-American woman in the state is twice as likely to die of cervical cancer than a white woman.While these statistics are harrowing, they are not surprising. Alabamas disproportionately high cervical cancer mortality rate is reflective of a more significant trend: States that limit access to womens health services tend to have the worst health outcomes for women. (Nakisa B. Sadeghi and Dr. Leana S. Wen, 1/10)

Colorado Sun:We Are Colorado ObGyns. Words Matter On Abortion Rights.If pregnant people and a medical procedure are going to be used as fodder for a political dispute, we all have an obligation to get the medical science and facts right. That means relying on doctors and medical professionals for their expertise, not politicians who are trying to use stigma, shame and inflammatory language to keep pregnant people from exercising their constitutional rights. Recently, Facebook took down a fact check of an anti-abortion video by three doctors after four male Republican senators objected. Thats not OK. (Dr Emily Schneider and Dr. Kristina Tocce, 1/12)

The Washington Post:I Thought My Second Baby Would Be Easier. And Then I Started Drowning.After four years, three miscarriages and an ectopic pregnancy, the second baby I had yearned for entered the world. Armed with four years of parenting experience, I thought I was better equipped to handle life with a newborn than I had been as a new mom. I had survived the sleepless nights, weathered the scary fevers that precede budding teeth and coached myself through the irrational fears that accompany caring for a completely helpless human. (Danielle Campoamor, 1/10)

Bloomberg:Obamacare Marches On As Republicans FlailState by state, my prediction that the Medicaid expansion made possible by the Affordable Care Act would eventually be universal is slowly coming true. Most Republican governors had originally rejected expansion and the federal money that finances it, but plenty of them are agreeing to compromises to make it happen. The latest? Kansas. That leaves 14 states to go, although those 14 still include both Texas and Florida, so were still talking about a lot of uninsured people. (Jonathan Bernstein, 1/10)

The New York Times:The F.D.A. Is In Trouble. Heres How To Fix It.The Food and Drug Administration is in distress. The agency is still the worlds leading regulator of food and medical products, responsible for ensuring the safety of some $2.6 trillion in consumer goods each year. That represents 20 cents of every dollar that Americans spend. But critics both inside and outside the sprawling agency say that the F.D.A.s standards have been slipping for some time. (1/11)

The Hill:China Has A New SARS-Like Virus How Serious Is It?The last several days of infectious disease headlines have been focused on a mysterious outbreak in Wuhan, China, that has many concerning harbingers. This cluster of pneumonia cases some of which are severe involves individuals who had exposure to a, since decontaminated, seafood market that housed many types of animals. (Dr. Amesh Adalja, 1/9)

The Washington Post:Puerto Ricans Should Never Forget How Trump Treated ThemHere's what Puerto Rico has endured over the past two years: a devastating hurricane that killed and displaced thousands of people and plunged the island into months of darkness; an incompetent and corrupt local government; a bungled and halfhearted emergency response from the federal government. Now, even as hurricane recovery remains incomplete, a new natural disaster: a 6.4-magnitude earthquake followed by powerful aftershocks. (1/12)

The Wall Street Journal:Cancel Culture Comes To ScienceAn unhappy side effect of the digital age is cancel culture. Anyone with an attitude of moral superiority and a Twitter account can try to shut down an event where opinions he dislikes are likely to be spoken. For several years the National Association of Scholars has inveighed against this infantile form of protest, which undermines free expression of ideas and legitimate debate. Now the cancel caravan has arrived at our door. (Peter W. Wood, 1/12)

The Washington Post:The Crisis In Foster CareThe theory behind foster care is grounded in an assumption of stability placing children whose parents are absent, dead or deemed unfit with stable families where community, schools and peers are roughly familiar. The reality is increasingly the opposite. An acute shortage of foster parents has produced a cohort of vulnerable children, many with drug-addicted parents, who are sent away, sometimes out of state, to live in juvenile detention centers, shelters and group homes. (1/11)

The New York Times:Trumps Weakening Of Environmental Rules Would Leave The Public In The DarkFifty years ago this month, President Richard Nixon signed one of the most effective laws ever written to protect the environment and strengthen democracy by ensuring that citizens would have a say over projects like highways and pipelines that directly affect their well-being. Now President Trump is trying to cripple it. (Sharon Buccino, 1/10)

Louisville (Ky.) Courier Journal:We Must Increase Access To Mental Health Care. Too Many People Are DyingWhen facing the homicide crisis in the U.S., nearly all of us, citizens and politicians alike, jump to the same questions: What industry is at fault? Who needs tighter regulations? Nobody is asking this about our nations mental health. Our healthcare system today clearly is not meeting the needs of Americans suffering from mental illness. Health insurance companies follow vague and unenforceable federal and state regulations that leave enrollees without access to timely mental health care. (Caitlin Liford, 1/10)

Stat:Welcome To The Bioengineering Culture ClashBioengineering, once viewed primarily as an academic discipline, is growing up. Our ability to engineer biology is on the verge of changing the landscape of health and health care. Tools and treatments that are engineered, not discovered CAR-T therapies for cancer, CRISPR for gene editing, stem cell therapies, and more are now making their way not just into new startups but into established industry. Just look at the first-generation CAR-T companies that have been acquired by major biopharma companies, like Bristol-Myers Squibb/Celgene acquiring Juno or Gilead acquiring Kite. (Vijay Pande, 1/10)

The New York Times:Everyone Knows Memory Fails As You Age. But Everyone Is Wrong.Im 62 years old as I write this. Like many of my friends, I forget names that I used to be able to conjure up effortlessly. When packing my suitcase for a trip, I walk to the hall closet and by the time I get there, I dont remember what I came for. And yet my long-term memories are fully intact. I remember the names of my third-grade classmates, the first record album I bought, my wedding day. (Daniel J. Levitin, 1/10)

The Washington Post:A Psychiatrist Feels Guilt For Making A Homeless Man Leave The ER.Tonight was yet another night on call in our emergency room a chilly winter night on which I did a cruel deed: I discharged a homeless man back out into the cold. This is a routine event in the life of psychiatry residents like myself. Normally, no one would bat an eye. It shouldnt have mattered to me, either except that the previous night Id had to walk home from the hospital parking garage in decidedly adverse weather. (Aarya Krishnan Rajalakshmi, 1/12)

The Washington Post:Prince Georges Countys Mental Health Programs Dont Work. When Will Someone Listen?Its Dec. 29, 1 p.m., and Im at a hospital in Prince Georges County. The emergency room is packed with people with varying degrees of illnesses. Many have severe colds; others have flu symptoms. Some have broken ribs or fractures and cuts and bruises from domestic violence (and broken hearts). Sadly, some have come here to die, their families clinging to the hope that this talented yet overwhelmed staff can whip up a miracle. (Sharon K. Vollin, 1/10)

See the article here:
Viewpoints: Medicaid Expansion Reveals How Liberal Policies Make For Good Politics; Hey, Congress, What's The Hold Up With Surprise Medical Bills? -...

Food manufacturers can put GMO labels on their products in 2020. Will they? – Food Dive

In grocery store freezer cases, Impossible Foods' ground plant-based meat stands out.

The packaging looks similar to its competitors in the space: heavy duty plastic formed around a square of the plant-based ground beef. A label proclaiming "burger made from plants" in all capital letters on the front, as well as a rundown of some nutritional benefits: 19 grams of protein per serving, no animal hormones or antibiotics, 0 milligrams of cholesterol.

The unique part is on the back of the package. In the lower right-hand corner, above symbols proclaiming the product is halal and kosher, is the new USDA-approved "Bioengineered" product label.

The Impossible Burger, which can "bleed" using heme made from genetically modified soy leghemoglobin, is among the first food products to use the soon-to-be federally mandated GMO label. According to AgNews, the symbol has been on product packages since at least October.

Jan. 1 began the official implementation period for the labeling law, which was signed by President Barack Obama in 2016. Large food companies can now start using the symbolto show consumers information about ingredients that meet the government's definition of bioengineered, more commonly known among consumers as GMOs. They can also use simple text,a smartphone-scannable code, a telephone number or text message to provide the disclosure.

According to the law, large manufacturers those with more than $2.5 million in annual receipts are required to have one of the approved forms of disclosure on their packages by Jan. 1, 2022. Attorneys and analysts told Food Dive they think most of the other products in the grocery store won't be featuring the disclosure until then.

Megan Poinski

"I don't think a lot is going to happen quickly," Jesse Zuehlke, general manager of Prime Label Consultants, told Food Dive. "I think my sense is people are feeling their way through this, and I think the supply chain is sort of trying to adjust."

Though it's been more than a year since USDA released its final regulations on the labeling law, there are still many issues that food manufacturers are trying to understand. Attorney Martin Hahn, a partner at Hogan Lovells who works with food manufacturers on several issues, has long said obtaining clarity on the labeling law and what does and does not fall under the government's definition of what needs a GMO label is paramount.

While Hahn told Food Dive many of his clients started working on the process of adding GMO information to their labels soon after the regulations were published,questions about what actually meets the definition of GMO material and how the disclosure can appear on labels stopped them from charging forward. And as new definitions published for the sake of clarity appear to bring onerous processes and more confusion into the mix, Hahn said it gives manufacturers and suppliers more cause to pull back on adding the disclosure.

"We're running into somewhat of a brick wall here because implementation requires that you develop the documentation from your ingredient suppliers, and the ingredient suppliers need to provide documentation that an ingredient's been refined and does not contain detectable levels of DNA," Hahn said. "And until we can get that document from the ingredient supplier, we're not going to be, as a finished food manufacturer, in a position to be in compliance."

On its face, the law is quite simple. Food products with detectable biologically engineered DNA need to be labeled. Items deliberately containing GMOs, like the Impossible Burger, have to tell consumers they were made through bioengineering. And products that inadvertently contain 5% or more of biologically engineered material need to have a disclosure.The law exempts meat, poultry, dairy and egg products from animals given genetically modified feed, as well as products having one of those items as a primary ingredient, like broth.

Food manufacturers that make products that contain GMOs, but don't meet these standards ingredients that are made from GMO crops that are so highly refined there is no detectable biologically engineered DNA, or inadvertently containing less than 5% GMO material are permitted to voluntarily disclose their GMO material, but are not required.

USDA representatives, who spoke to Food Dive on background, said the department may receive complaints about improper disclosure between now and the 2022 mandatory deadline, but will not enforce the labeling law until then. And even then, enforcement is likely to only come from complaints. The disclosure law is run out of the department's Agricultural Marketing Service, which is not an enforcement agency, and USDA will not be in stores examining labels.

"I don't think a lot is going to happen quickly. I think my sense is people are feeling their way through this, and I think the supply chain is sort of trying to adjust."

Jesse Zuehlke

General manager, Prime Label Consultants

However, there's much more to how the law is interpreted. Many manufacturers are working to determine if their ingredients meet the definition of biologically engineered, and it's not entirely clear what the testing procedure is. After all, according to USDA data, GMOs are widespread in common food crops 94% of all soy grown in the U.S., 83% of domestic corn and, according to statistics reported by Harvest Public Media, 95% of U.S. sugar beets. Many food products contain the refined products of these crops, so it's vital for manufacturers to know whether there's anything that needs to be disclosed.

"They are guilty until proven innocent under this rule, if you will," Zuelhke said. "...I need to have data on hand that proves that they're non-BE. And it's unclear what the rules of the road are. ...I think that may help shake things loose when some of that gets resolved."

While USDA representatives told Food Dive they are providing more information as quickly as they can, there are still gray areas. And some information intended to provide additional clarification actually has had the opposite effect, attorneys and analysts said.

A draft instruction that lays out how to validate a refining process basically the way to ensure that a certain refined ingredient does not need to be constantly tested to prove the absence of detectable GMOs has confused many, Hahn said. The draft was first published Dec. 17. Hahn said the regulation introduces food safety terminology to this process a completely different realm of food manufacturing, since GMOs have nothing to do with whether food is safe and requires ingredient suppliers to specifically designate the steps in the process that actually make the DNA non-detectable and monitor them.

"It would appear based on the draft instruction that there's an expectation that the industry would be expected to do all this continual testing, which seems to be unnecessarily burdensome and really costly," he said.

Earlier this month, USDA reopened the comment period on that instruction, based on the year-end holidays and extension requests. People will have until Feb. 7 to offer input, according to the announcement in the Federal Register.

Attorneys and consultants working with labeling had nothing negative to tell Food Dive about USDA's management of figuring out the law so far.

"I think they are being incredibly responsive, and I think we're going to continue to get a lot of information from AMS that's going to help with the rollout in the interim," Robert Hibbert, a partner at law firm Morgan Lewis, who advises clients on food-related regulations, told Food Dive. "There's certainly some questions about some of the detail of that regulation. A lot of that's been cleared up."

Bioengineered Arctic apples do not brown when cut.

Okanagan Specialty Fruits

The GMO labeling movement was born out of consumers who wanted more information about what is in their food. The implications of actually having a label on a product, however, might not be good for consumer perception.

Across the board, studies on GMOs in food have shown consumers don't understand what they are and are wary to try products containing them. In 2018, pro-GMO organization GMO Answers found 7 out of 10 adults don't really know what GMOs are, and less than a third are comfortable having GMOs in their food. The same year, a study by researchers at Washington University in St. Louis and published in the Annual Review of Nutrition found even 20 years after wide cultivation of GMO food began, many consumers are still "grossed out" by them.

Kathy Musa-Veloso, director of health claims in the food and nutrition group of quality assurance testing company Intertek,presented some other study findings last summer at the Institute of Food Technologists conference. Consumers said they felt GMO crops some of which are altered to be more pest-resistant were harmful to the environment.In another study,the vast majority of people who avoid GMO crops said they were concerned about human health,although most health professionals say GMOs are just as healthy as their non-biologically engineered counterparts.

As far as a label goes, a consumer study of a product with a mocked up GMO label showed nearly a third of consumers noticed it, Musa-Veloso shared. And of those consumers who took notice, about half were influenced not to buy the product.

"We can sit here and talk about bioengineering, but most consumers don't necessarily even resonate with the term 'bioengineering.' So how consumers will react is going to become one of the bigger question marks."

Robert Hibbert

Partner, Morgan Lewis

Adding to the potential confusion for consumers is how these ingredients will be represented on the label. While "GMO" has been the popular terminology for decades, the federal law requires these kind of ingredients to be called "bioengineered" or "derived from bioengineering." This terminology is completely accurate, but Hibbert pointed out it's another degree of uncertainty for consumers.

"We can sit here and talk about bioengineering, but most consumers don't necessarily even resonate with the term 'bioengineering,' " he said. "So how consumers will react is going to become one of the bigger question marks."

From where he sits, Hibbert said he sees manufacturers are keeping product reformulation on the table as a potential option to avoid the GMO label. However, he said, many are still trying to figure out whether they need to disclose anything.

Soon after the GMO labeling law was passed, several companies did high-profile reformulations to replace ingredients that may lead to disclosure.Del Monte reformulated fruit, vegetable and tomato productswith non-GMO ingredients, as did Hormel's Applegate brand. Grocery store Earth Fare removed genetically modified ingredientsfrom its private-label products. In the last two years, more brands may have worked toward reformulation, but quietly.

It's still up in the air whether manufacturers will take steps to educate consumers on what "bioengineered" (or "GMO," for that matter) actually means. Zuelhke said this has almost always been a question, especially considering some GMOs were created as a more high-tech alternative to cross-breeding to do things like increase yields or become more pest and disease resistant.

Hibbert said that companies could have an opportunity to explain what GMOs mean and are through the disclosure itself. After all, the disclosure law allows companies to offer a smartphone-scannable panel that provides a product's GMO information. It isn't inconceivable that manufacturers could use the same website that provides that information to explain the reasons behind using GMO-derived ingredients. The law also allows the disclosure to come through a telephone number or text message, both of which could also provide more in-depth information about GMOs.

However, Hibbert said, it's likely that some food and drink categories have consumers who are less concerned with whether a product contains GMOs. In the more natural or health-oriented food space, he said, people are much more likely to be paying attention. In other areas, like private label, which entails many different kinds of product lines, manufacturers are likely to opt for digital disclosure.

Consumer acceptance of the label and the backstory of the products it is on has always been a big question for industry, Hibbert said. And it's a question that it will be difficult to answer until the labels start to appear in larger quantities on grocery store shelves.

"Will consumers understand this?" Hibbert asked. "If they simply understand this as being genetically engineered, [they could think] 'Maybe I'm OK with that.' And if not, then yes, we'll look at a reformulation, but [companies are] still sort of in fact-finding mode on their own products and on the consumer front first before they can reach a decision on whether to reformulate."

See the original post here:
Food manufacturers can put GMO labels on their products in 2020. Will they? - Food Dive

Bacillus Licheniformis Market Size, Share, Segmentation, Growth Drivers And Opportunities Analysis For Forecast Period 2017-2025| Qy Research, Inc -…

Los Angeles, United State,, The research study presented in this report offers a complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the global Bacillus Licheniformis market. It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global Bacillus Licheniformis market. The authors of the report have segmented the global Bacillus Licheniformis Market as per product, application, and region. Segments of the global Bacillus Licheniformis market are analyzed on the basis of market share, production, consumption, revenue, CAGR, market size, and more factors. The analysts have profiled leading players of the global Bacillus Licheniformis market, keeping in view their recent developments, market share, sales, revenue, areas covered, product portfolios, and other aspects.

Our PESTLE, Porters Five Forces, and SWOT analyses give a thorough presentation of the global Bacillus Licheniformis market from different perspectives and angles. The research study has been prepared with the use of in-depth qualitative and quantitative analyses of the global Bacillus Licheniformis market. We have also provided absolute dollar opportunity and other types of market analysis on the global Bacillus Licheniformis market. All findings and data on the global Bacillus Licheniformis market provided in the report are calculated, gathered, and verified using advanced and reliable primary and secondary research sources. The regional analysis offered in the report will help you to identify key opportunities of the global Bacillus Licheniformis market available in different regions and countries.

Get PDF template of this report: https://www.qyresearch.com/sample-form/form/1062492/global-bacillus-licheniformis-market

Key Players of the Global Bacillus Licheniformis Market

Wuhan Natures Favour BioengineeringHenan Yi Kang BioengineeringBeihai Qunlin Shengwu GongchengXianpuairui TechnologyCangzhou Industrial Biological TechnologyZhengzhou Jinbaihe Biology EngineeringShandong Gaolong Biology TechnologyCangzhou Wangfa Biology TechnologyCangzhou Huayu Biology TechnologyCangzhou Zhongxin Biology TechnologyShandong Tianxing Bio-Fechnology

Global Bacillus Licheniformis Market: Segmentation by Product

PowderSolutionOthers

Global Bacillus Licheniformis Market: Segmentation by Application

MedicalAgricultureOthers

Global Bacillus Licheniformis Market: Segmentation by Region

The Middle East and Africa (GCC Countries and Egypt) North America (the United States, Mexico, and Canada) South America (Brazil etc.) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Enquire for customization in Report @https://www.qyresearch.com/customize-request/form/1062492/global-bacillus-licheniformis-market

Table of Contents

Market Overview: The report begins with this section where product overview and highlights of product and application segments of the global Bacillus Licheniformis market are provided. Highlights of the segmentation study include price, revenue, sales, sales growth rate, and market share by product.

Competition by Company: Here, the competition in the global Bacillus Licheniformis market is analyzed, taking into consideration price, revenue, sales, and market share by company, market concentration rate, competitive situations and trends, expansion, merger and acquisition, and market shares of top 5 and 10 companies.

Company Profiles and Sales Data: As the name suggests, this section gives the sales data of key players of the global Bacillus Licheniformis market as well as some useful information on their business. It talks about the gross margin, price, revenue, products and their specifications, applications, competitors, manufacturing base, and the main business of players operating in the global Bacillus Licheniformis market.

Market Status and Outlook by Region: In this section, the report discusses gross margin, sales, revenue, production, market share, CAGR, and market size by region. Here, the global Bacillus Licheniformis market is deeply analyzed on the basis of regions and countries such as North America, Europe, China, India, Japan, and the MEA.

Application or End User: This part of the research study shows how different application segments contribute to the global Bacillus Licheniformis market.

Market Forecast: Here, the report offers a complete forecast of the global Bacillus Licheniformis market by product, application, and region. It also offers global sales and revenue forecast for all years of the forecast period.

Upstream Raw Materials: The report provides analysis of key raw materials used in the global Bacillus Licheniformis market, manufacturing cost structure, and the industrial chain.

Marketing Strategy Analysis and Distributors: This section offers analysis of marketing channel development trends, indirect marketing, and direct marketing followed by a broad discussion on distributors and downstream customers in the global Bacillus Licheniformis market.

Research Findings and Conclusion: This is one of the last sections of the report where the findings of the analysts and the conclusion of the research study are provided.

Appendix: Here, we have provided a disclaimer, our data sources, data triangulation, market breakdown, research programs and design, and our research approach.

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.

Read more:
Bacillus Licheniformis Market Size, Share, Segmentation, Growth Drivers And Opportunities Analysis For Forecast Period 2017-2025| Qy Research, Inc -...

Bacillus Subtilis Market 2019-2025: Onset Of Advanced Technologies To Upsurge The Growth – Industry Mirror

The Report Titled on Global Bacillus Subtilis Market Size, Status and Forecast 2019-2026 provides a basic overview of the Bacillus Subtilis industry including:Executive Summary, Definitions, Classifications, Applications, Segment Analysis,and Market Overview; manufacturing technology; cost structures, product specifications; raw materials and so on. This Bacillus Subtilis market report enhanced on worldwide competition by leading manufactures like (Bayer AG, BASF SE, Jocanima Corporation, Tonglu Huifeng, Kernel Bio-tech, Wuhan Natures Favour Bioengineering Co., Ltd., Real IPM, ECOT China, and Qunlin) which providing information such asCapacity, Production, Production Value, Cost/Profit, Supply/Demand and Import/Exportand so on. There are 3 key segments covered in this Bacillus Subtilis market report: competitor segment, product type segment, end use/application segment.

Bacillus Subtilis MarketReport Structureat a Glance:Macroeconomic Factors & 6 Year Forecast Factors 2019-2026,Bacillus SubtilisMarketTaxonomy, Pricing & Regulatory Factors Analysis, Value Chain Analysis,MarketDynamics(Key Drivers, Key Restraints, Recent Trends, Upcoming Opportunities).

Get Free Sample PDF (including full TOC, Tables and Figures)of Bacillus Subtilis[emailprotected] https://www.coherentmarketinsights.com/insight/request-sample/1253

Summary of Bacillus Subtilis Market:In 2018, the global Bacillus Subtilis market size was million US$ and it is expected to reach million US$ by the end of 2026, with a CAGR of during 2019-2026.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry[emailprotected] https://www.coherentmarketinsights.com/insight/talk-to-analyst/1253

Bacillus Subtilis Market: Regional analysis includes:

Important Key Questions Answered In Bacillus Subtilis Market Report:

What will the Bacillus SubtilisMarket Growth Rate, Overview, and Analysis By Typeof Bacillus Subtilis in 2026?

What are the key factors affecting market dynamics? What are theDrivers, Challenges, and Business Risksin Bacillus Subtilis market?

What is Dynamics, This Overview Includes Analysis of Scope and price analysis of top Manufacturers Profiles?

Who AreOpportunities, Risk and Driving Forceof Bacillus Subtilis market? Knows Upstream Raw Materials Sourcing and Downstream Buyers.

Who are the key manufacturers in space? Business Overview by Type, Applications, Gross Margin, and Bacillus Subtilis Market Share

What are theOpportunities and Threats Faced By Manufacturersin the global Bacillus Subtilis market?

Contact:

Mr. Raj ShahCoherent Market Insights1001 4th Ave,#3200Seattle, WA 98154Tel:+1-206-701-6702Email:[emailprotected]

Visit Our Blog:https://bit.ly/aman

The rest is here:
Bacillus Subtilis Market 2019-2025: Onset Of Advanced Technologies To Upsurge The Growth - Industry Mirror

Filling Equipment Market will Generate Massive Revenue in Future: Valent U.S.A. Corporation,Jiangsu Fengyuan Bioengineering Co Ltd – Trade Examiner

MarketResearch.Bizadded latest industry report on GLobal Filling Equipment Market 2019. Filling Equipment Market report offers Key Drivers, Technology Growth and Opportunities, Qualitative Insights, Growth Rate, Revenue and Forecast (2019-2028). This market study report gives a top to a bottom investigation relating to potential drivers powering this industry. The investigation additionally includes significant bits of knowledge about profitability prospects, market size, development elements, and revenue estimation of the business vertical. The investigation further causes to notice the aggressive setting of renowned market contenders including their product contributions and business systems.

The report gives an extensive assessment of the Filling Equipment Market promote by sorts, applications, players and districts. This report moreover shows the 2019-2028 generation, Consumption, salary, Gross edge, Cost, Gross, a bit of the general business, CAGR, and Market affecting components of the Filling Equipment Market.

Leading Filling Equipment Industry Players Served In This Report Are:Accutek Packaging Equipment Companies Inc, GEA Group AG, JBT Corporation, Krones Group AG, Scholle Packaging, Filling Equipment Co Inc, Bosch Packaging Technology, KHS GmbH, Ronchi Mario S.p.A., Tetra Laval

To obtain all-inclusive information on forecast analysis of global Filling Equipment Market, request a Free PDF brochure here:https://marketresearch.biz/report/filling-equipment-market/request-sample

In the first section of the Filling Equipment Market report, we offer a table of content, followed by a list of figures on Filling Equipment market scenario. The next section offers a Filling Equipment market definition as well as the brief explanation of the various products and Filling Equipment market segmentation. Filling Equipment market report also includes the list of acronyms and sources used to gather and analyze data and information for Filling Equipment market report.

The third section of the Filling Equipment market research report entails a brief list of Filling Equipment market drivers, restraints, Filling Equipment market opportunities, and threats (DROTs). The Filling Equipment market intelligent report also offers insights on various Filling Equipment market trends in regions, countries, and markets as per segmentation, as well as insights and crucial information obtained from various sources including primary and secondary, annual reports, the Internet, and others.

The final section of Filling Equipment market research study comprises detailed profiles of key players in the Filling Equipment market and SWOT analysis of each company, apart from strategies, acquisitions, and mergers. Objective of Filling Equipment industry report: Sections of the Filling Equipment market report are created and designed specifically to offer readers a clear, clean, and insights into historical, estimated, and Filling Equipment market revenue (US$ Mn/Bn) estimation and projection, Filling Equipment market Compounded Annual Growth Rate (CAGR %), and volume in measure as applicable to the Filling Equipment product/market. We offer illustrations, charts, tables, and figures to support our findings and analysis, in addition to key findings for Filling Equipment markets in regions and countries.

Topographical Regional Analysis: GlobalFilling Equipment Market

1. North America (United States, Canada)

2. Europe (Germany, Spain, France, UK, Russia, and Italy)

3. Asia-Pacific (China, Japan, India, Australia, and South Korea)

4. Latin America (Brazil, Mexico, etc.)

5. The Middle East and Africa (GCC and South Africa)

Market Segmentation:

The report contains a detailed segmentation analysis of the global Filling Equipment market, where all of the segments and sub-segments are studied in terms of growth, market share, growth rate, and other important factors. It also gives the allure index of segments so that Filling Equipment market players can be brief about lucrative revenue pockets of the global Filling Equipment market. The comprehensive evaluation of segments offered in the report will help you to assist your investments, business strategies, and points to focus on the right areas of the global Filling Equipment market.

Global filling equipment market segmentation by type:Rotary FillersVolumetric FillersAseptic FillersNet Weight FillersOther Filling Equipment

Global filling equipment market segmentation by process:ManualSemi-AutomaticAutomatic

Global filling equipment market segmentation by application:Food & BeveragePharmaceuticalCosmeticOthers

In This Study, The Years Considered To Estimate The Size Of Filling Equipment Market Are As Follows:

History Year: 2013-2018 || Base Year: 2018 || Estimated Year: 2019 || Forecast Year: 2019 to 2028

Inquire/Speak To Expert for Further Detailed Information About Filling Equipment Report:https://marketresearch.biz/report/filling-equipment-market/#inquiry

The focus of theFilling Equipment MarketReport:

The Study Offers a Detail Analysis of the Global Filling Equipment Market and Ongoing & Upcoming Trends To Elucidate Imminent Investment Pockets.

Changing Filling Equipment Market Dynamics

Key players Business Strategies and Product Offerings

In-depth Analysis Of Market Segmentation

Filling Equipment Market Analyze and Forecast On The Basis of Type, Process, Application, And Region.

Table of Content:

Chapter 1 Industry Overview of Filling Equipment

Chapter 2 Manufacturing Cost Structure Analysis

Chapter 3 Technical Data and Manufacturing Plants Analysis of Filling Equipment

Chapter 4 Global Overall Market Overview

Chapter 5 Filling Equipment Regional Market Analysis

Chapter 6 Major Manufacturers Analysis

Chapter 7 Development Trend of Analysis of Filling Equipment Market

Chapter 8 Filling Equipment Marketing Type Analysis

Chapter 9 Conclusion of the Global Filling Equipment Market Professional Survey Report 2019

Chapter 10To be Continue

In conclusion, the industry report serves the comprehensive overview of the parent Filling Equipment market comprising key players, ongoing and past years information which will very beneficial for all the Filling Equipment business competitors. In short, Filling Equipment market research report serves a vital and essential data of major key vendors, with Filling Equipment company profiles, past and the current market outlook which would help new launch Filling Equipment markets to make the good impression on the market.

About Us:

MarketResearch.Biz is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. The company offers services such as data mining, information management, and revenue enhancement solutions and suggestions. We cater to industries, individuals, and organizations across the globe, and deliver our offerings in the shortest possible turnaround time.

We provide the best in class customer services and our customer support team is always available to help you with your research queries. Thanks for reading this article.

Contact Us:

Mr. Benni Johnson

Prudour Pvt. Ltd.

420 Lexington Avenue, Suite 300 New York City, NY 10170, United States

Tel:+ 1-347-826-1876

Website:https://marketresearch.biz/

Email ID:[emailprotected]

Read more:
Filling Equipment Market will Generate Massive Revenue in Future: Valent U.S.A. Corporation,Jiangsu Fengyuan Bioengineering Co Ltd - Trade Examiner

Chinese biotechnology dominates US Senate hearing on biological threats – Homeland Preparedness News

Shutterstock

China is rapidly gaining on the United States when it comes to creating technology that mitigates disease threats and developing pharmaceuticals faster, and its a phenomenon driven by a philosophy that the state, military, and the private sector are one in the same.

That was the testimony of Tara J. OToole, senior fellow and executive vice president at In-Q-Tel, before the U.S. Senate Armed Services Subcommittee on Emerging Threats and Capabilities. The hearing, Biological Threats to U.S. National Security, examined everything from Chinas push to develop biotechnology infrastructure to luring research scientists away from the United States to work in China.

China has said repeatedly and forcefully, and theyre backing up their words with actions, that they intend to own the biorevolution, OToole said. And they are building the infrastructure, the talent pipeline, the regulatory system, and the financial system they need to do that.

China is partly accomplishing this by combining its internet giants, such as Alibaba, with its biotech companies. The combined strength of these companies research focuses on the industrialization of artificial intelligence in which China is institutionalizing it whereas the United States is only experimenting with it, OToole added.

Chinas goal is to make biotechnology 5 percent of the countrys GDP by 2020. China has changed regulations for its own version of the Food and Drug Administration to be more like that of the United States in order to more easily market to the world. The country has created a talent pipeline that incentivizes its own students to go into the life sciences and bioengineering. China also has at least 20 programs intended to bring scientific talent from the rest of the world.

There are good reasons China is going after the biorevolution: it has the highest incidences of cancer on earth and the population is aging. It also must find an affordable way to deliver health care to a rising middle class.

And China is delivering health care to the world. The country is the largest producer of active pharmaceutical ingredients. However, reliance on foreign pharmaceuticals has national security implications. As many as 80 to 100 percent of critical drugs are manufactured outside the United States. U.S Sen. Gary Peters (D-MI) told the committee that following the 2001 anthrax attacks, the U.S. was dependent on a single foreign source for a broad-spectrum antibiotic to treat anthrax.

To what extent is the U.S. reliant on foreign sources for key drug products and medical supplies such as syringes and needles and other critical medical supplies that we would need to respond to a biological attack today? Peters asked the panel of experts.

The United States is critically dependent on China for several drugs and has been shipping manufacturing capacity to Asia for more than a decade.

There isnt a CEO of a major pharma company that hasnt been recruited by China to build facilities there, OToole said.

To address the drug supply chain, the United States has begun exploring the possibility of using synthetic biology to make active pharmaceutical ingredients, especially in response to epidemics.

If there were a natural pandemic in which the entire world needed drugs, Im sure China, as we would, take care of its own people first. Yet, we dont have the surge capacity to produce enough very common, well-used medicine in time to deal with an epidemic, OToole said.

Thomas Inglesby, director of the Center for Health Security at the Johns Hopkins Bloomberg School of Public Health, told the committee that the U.S. treats medicines too much like commodities that can be sourced for the lowest price somewhere in the world.

In a crisis, everyone in every part of the world would be looking for medicine at the same time, Inglesby said. There should be at least a strategic examination of the kinds of things we must have, and we should consider how to bring some of those medicines back to the U.S. Obviously that cant be done with all medicines. Were an interconnected world. But for national health crises, we should be thinking about making them here.

Part of the problem is that the United States has not done a good job at translating biology to products, OToole said, or building infrastructure for securing and promoting the bioeconomy. Our translational infrastructure for biology is mostly coming from small start-up companies in the private sector, which are the innovation engines for biology, but do not provide the robust infrastructure to manage epidemics, whether deliberate or natural.

The experts made the following recommendations:

* Take on synthetic biology as a national security priority;* Use the National Defense Education Act to improve access to stem education and establish greater scientific careers within the U.S. government;* The contingency fund levels for the Centers for Disease Control and Prevention and USAID should be increased and sustained;* Support and strengthen the militarys infectious disease research laboratories;* Provide strong, coherent leadership at the National Security Council essential for guaranteeing effective oversight, long before a crisis emerges;* The U.S. Department of Agriculture should prioritize stronger crop surveillance, animal wildlife surveillance, more support for animal vaccine development, and more funding for agricultural biodefense overall;* Strongly support the biological weapons convention.

During epidemics, the U.S. should be able to immediately create diagnostics that could be used similarly to a pregnancy test so that people can determine for themselves who is sick and who isnt. Officials should be able to rapidly develop a new vaccine in response to an epidemic, OToole added.

These same tools also apply to diseases that affect agriculture and the U.S. animal supply. More than half of all infections that people contract are spread by animals.

Ill start by acknowledging that mother nature is a really good terrorist, Julie L. Gerberding, co-chair of the Commission on Strengthening Americas Health Security at the Center for Strategic and International Studies, told the committee. China today is experiencing a dreadful outbreak of swine fever that has probably cost the death or culling of at least 50 percent of their entire population of pork which is a major source of protein for people in China. So, this is a major socioeconomic threat to the state of China today and thats mother nature.

Swine fever, however, is not spread to humans, though it has a devastating economic impact. And U.S. farmers are concerned about trade and travel bringing such infectious diseases to this country.

I would say that the first alarming statistic is that we spend probably about 100 times less on agricultural threats than we do on human threats, Inglesby said. I think there are many reasons for this. But one includes a kind of reluctance within the U.S. government to talk about this threat until quite recently.

The rest is here:
Chinese biotechnology dominates US Senate hearing on biological threats - Homeland Preparedness News

A ‘New Skin’ Could Allow You To Virtually Reach Out And Touch Anyone – Nature World News

Nov 21, 2019 08:41 AM EST

Scientists have created a tool that enables humans to experience the sensation of touch withinvirtual reality.

The 'smart skin' machine consists of a soft, lightweight sheet of electronics that sticks to the body. The new innovation utilizes a mixture of vibration, pressure, and motion to mimic the sense of touch for users.

The study outlining the "skin-integrated wireless haptic interfacesfor virtual and augmented reality" was issued in thescientific journalNature.

Nanoengineer John Rogers - a professor of bioengineering at Northwestern University who is the lead author of the study - explained that human touch is probably the most profound, most meaningful heartfelt connection that you can build with a loved one or friends.

Hence, Rogers and his team at Northwestern came up with the idea of a new wireless and battery-free smart skin that could shift the course of this technology. Their smart skin can contour to the body and deliver sensory input -what you'd feel when using it - through a fast, programmable collection of tiny vibrating disks installed in a soft, flexible material.

The authors explained their invention could have severe implications in various areas ranging from video games to prosthetics. The whole new skin's process is "very complex," according to their paper.

"The sense of touch is a [compilation] of [different] sensations, [including] temperature, pressure, and pain. Until now, [there] has been a great challenge to [unite the] sensations of touch into virtual and augmented reality.

"In comparison to the eyes and the ears, the skin is a relatively underexplored sensory interface for VR and AR technology that could, nevertheless, greatly enhance experiences at a qualitative level, with direct relevance in areas such as communication, entertainment, and medicine."

Rogers and his team say the technology could have several applications. The system, for instance, could be utilized to send touch to a loved one through social media or to replicate a specific shape of an object held in a prosthetic hand. The invention could also be used by video gamers to feel hits when playing combat video games.

Virtual realityremains a niche technology, usually used for industrial applications and by a small portion of video gamers. Experts anticipate that improvements like these would help the technology finally break into the mainstream.

Luke Osborn - a postdoctoral researcher at the Johns Hopkins University Applied Physics Laboratory who was not involved in the study - said he was excited to see how the new technology would progress in the coming years.

"What's [especially interesting] about their [output] is how they [combine] wireless power delivery," Osborn said.

Osborn's team previously produced a sensory feedback tool called an"e-dermis,"which fits prosthetic hands and mimics nerve endings, allowing amputees to feel any nerve sensation.

The Northwestern teams' new smart skin would add to the technology, allowing amputees "to [know] how much force they're using when they grasp an object as well as how hot or cold the object is," Rogers said.

"You can also [use multiple] devices at [various] areas of interest across the body, and can [wirelessly and simultaneously] control all of them," he added.

The medical applications of the technology motivate Rogers' team. They are currently working with stroke victims who cannot swallow, using a smart skin to help trigger and time swallows with respiration to avoid choking.

2018 NatureWorldNews.com All rights reserved. Do not reproduce without permission.

Read more here:
A 'New Skin' Could Allow You To Virtually Reach Out And Touch Anyone - Nature World News

Ottawa-based treatment an unprecedented leap forward in addressing damage after heart attack – Ottawa Citizen

Veronika Sedlakova, post-doctoral fellow (L), Sarah Mclaughlin, PhD(c), and Dr. Emilio Alarcon, principal investigator and laboratory director, University of Ottawa Heart Institute, have developed a recombinant human collagen matrix for cardiac tissue repair. October 24, 2019. Errol McGihon / Postmedia

It took years for Emilio Alarcon and his University of Ottawa Heart Institute research team to fully believe what they were seeing that a gel they had developed containing human collagen was repairing damaged hearts in mice.

They repeated their research study several times, coming up with randomized, blinded results, just to make sure the findings were correct.

We had to complete it many times because we couldnt believe it, he said.

The results of that work, five years in the making, were published in the prestigious journal Nature Communications on Friday. Alarcon and Erik Suuronen, a scientist in the division of cardiac surgery and director of its biomaterials and regeneration program, are lead authors.

The injectable material is the first in the world prepared using human collagen and is being called an unprecedented leap forward in addressing repair of cardiac muscle after a heart attack.

The work is still years away from clinical use on humans, but the findings are expected to attract attention because of the potential of the gel, which is designed to be injected into the hearts of patients with damaged heart tissue after a heart attack.

Alarcon said his team believes it performs better than any of the cell-based therapies or drug treatments currently available. The treatment works, he said, by increasing the number of cardiac muscle cells and blood capillaries in the tissue around damaged areas of the heart. The gel also helps bring more wound-healing cells to the site to promote repair.

Heart diseases are the leading cause of death around the world, and coronary artery disease, which can lead to a heart attack, is the most common.

About 10 per cent of people who have a heart attack (or myocardial infarction) will develop scarring and thickening of the heart wall that can lead to heart failure, which has a high mortality rate and its treatment is costly to the health system.

Alarcon noted that patients in remote areas without easy access to health care and those who dont seek immediate treatment or dont know they had a heart attack are more likely to suffer heart muscle damage. The treatment being developed by the heart institute team restored heart function in mice with scarred cardiac muscle.

The heart institutes BioEngineering and Therapeutic Solutions (BEaTS) team are hopeful their human collagen gel will one day lead to a recovery of heart function and prevent heart failure in humans, said Alarcon, but more testing is required.

The study published Friday is a first step toward that potential treatment, he said.

In Canada, approximately 600,000 patients live with advanced heart failure and health-care costs amount to more than $2.8 billion every year. As people live longer, both the number of patients and the cost of treatments are likely to increase.

ALSO IN THE NEWS

Mistake airline fares are the best way to score super cheap plane tickets. Heres how

Canadian scientists say they have produced the rarest drug on earth for cancer treatment

Fourth federal government office building treated for bedbugs

See the original post:
Ottawa-based treatment an unprecedented leap forward in addressing damage after heart attack - Ottawa Citizen

Trailblazer R21 Awards | National Institute of Biomedical …

The Trailblazer R21 Award is an opportunity for New and Early Stage Investigators to pursue research programs of high interest to the NIBIB at the interface of the life sciences with engineering and the physical sciences. The Trailblazer Funding Opportunity Announcement (FOA) employs an R21 Exploratory/Developmental Research Grant mechanism, enhanced to provide $400,000 in direct costs over three years, allowing sufficient time and resources to pursue a new or emerging research program. A Trailblazer project may be exploratory, developmental, proof of concept, or high risk-high impact, and may be technology design-directed, discovery-driven, or hypothesis-driven. Importantly, applicants are expected to propose research approaches for which there are minimal or no preliminary data.

Access the Trailblazer announcement here:https://grants.nih.gov/grants/guide/pa-files/PAR-18-207.html

Notice - the expiration date for the Trailblazer grant has been extended to January 8, 2020. Details at NOT-EB-19-014.

To find out if you are eligible, see the NIH definition of New and Early Stage Investigators: https://grants.nih.gov/policy/new_investigators/index.htm

For more information about the NIBIB R21 Trailblazer, see our Frequently Asked Questions.

See original here:
Trailblazer R21 Awards | National Institute of Biomedical ...

American Oriental Bioengineering, Inc. (AOBI) Upgraded to Hold at ValuEngine – The Cerbat Gem

American Oriental Bioengineering, Inc. (AOBI) Upgraded to Hold at ValuEngine
The Cerbat Gem
American Oriental Bioengineering, Inc. (OTCMKTS:AOBI) was upgraded by equities research analysts at ValuEngine from a sell rating to a hold rating in a research note issued to investors on Wednesday. Shares of American Oriental Bioengineering ...

See the article here:
American Oriental Bioengineering, Inc. (AOBI) Upgraded to Hold at ValuEngine - The Cerbat Gem

GMU students make 3D printed prosthetic arm for violinist | khou.com – KHOU

Students from George Mason University design prosthetic arm for violist

Peggy Fox, WUSA 9:46 PM. CDT April 20, 2017

FAIRFAX, VA (WUSA9) - A new beginning for a Fairfax County girl who has just received a new prosthetic arm that was designed and 3-D printed by George Mason University college students.

Isabella Nicola, 10, has been raised by her mother, Andrea Cabrera, to never say never.

"My mom's phrase is, when you say 'I can't do it', it's 'I can't do it yet,'" said Nicola.

The fifth grader signed up to play violin in the strings program at Island Creek Elementary in Franconia last year, even though she knew it'd be a little difficult.

RELATED:Dog rescued from slaughterhouse gets prosthetic legs

She was born with an incomplete left arm. Her music teacher fashioned a makeshift prosthetic arm out of PVC to hold her bow. Then he a called his alma mater and got the engineering department on board.

But now, Isabella has a bright pink, custom-made, brand new prosthetic arm that allows her to hold and move the bow properly.

"I have to say thank you to them because without them I couldn't really be able to play," said Nicola.

The five students have been working as a team for more than a year on their capstone senior project. It was designed, 3D printed, and pieced together by five George Mason University bioengineering students, Yasser Alhindi, the lead, Abdul Gouda, Mona Elkholy, Ella Novoselsky and Racha Salha.

Dr. Elizabeth Adams, a GMU music teacher, explained that a player's arm movement affects the violin's sound. Adams worked with the students and Isabella, providing advice.

The faculty mentors are Wilsaan Joiner and Vasiliki Ikonomidou. Laurence Bray is head of the bioengineering department.

"We were brainstorming ideas right away. We were aiming to take the strain off her shoulder to make her as comfortable as possible," said Ella Novoselsky.

RELATED:Injured animals get life-changing prosthetics

"It's amazing. They didn't have any background when they started, of the mechanical engineering aspect. I'm amazed. When they came to me with all those designs, and they told me, this is going to go there and this will go like that. 'Ok, sure,'" saidVasiliki Ikonomidou, one of the mentors said about the student designers.

For Thursday's hand-off, the students had a surprise for Isabella. They also made a grip so that she can ride bike with both arms. Isabella beamed as she held it like she was holding the handlebars.

"Very cool and nice...They thought about other things. They went above and beyond," said Isabella.

She and the college students hit if off from the start. At their first meeting, Racha Salha said Isabella was "making jokes and laughing. We were actually the ones who were nervous....She's amazing."

"I want her to play the violin and love playing the violin and be excited. And I want her to believe she can do anything she wants," said Ella Novoselsky.

The bioengineering department has already received more inquiries from other people, so another group of students could soon have a new project on their hands.

2017 WUSA-TV

Follow this link:
GMU students make 3D printed prosthetic arm for violinist | khou.com - KHOU

News in brief – Highlander Newspaper

UCR Researchers Create Sensor to Measure Liquid Samples

Researchers at UCR have recently developed a sensor to measure samples by using a piece of glass tubing, which will help when measuring samples that are in liquid.

The sensor can be used in many different applications including toxicology, developmental biology, plant sciences and biomaterials engineering. The research was focused on toxicology and how it could improve the current technology that is expensive, time-consuming and labor-intensive.

The team was lead by William Grover, assistant professor of bioengineering at Bourns College of Engineering, and Shirin Mesbah Oskui, a bioengineering and biomedical engineering doctoral student in Grovers lab.

The research team discovered that when they bent a piece of glass tubing into a U shape and attached a speaker to it, it could be used to measure the mass density and volume of the sample inside the tube. Their sensor was expanded from a similar technique that was developed at MIT for weighing single cells.

They hope that this new technique will help further advance the field because of its automation, portability and low cost.

The team also consisted of Heran Bhakta, a graduate student in bioengineering, Graciel Diamante, a graduate student in environmental sciences, Huinan Liu, associate professor of bioengineering and Daniel Schlenk, professor of aquatic ecotoxicology.

Michael Nduati to represent UCR in NMQF 40-Under-40 List

Michael Nduati of the UCR School of Medicine has been chosen by the National Minority Quality Forum (NMQF) as one of the 40 Under 40 Leaders in Minority Health.

Nduati currently serves as the senior associate dean for clinical affairs and CEO of UCR Health. As the senior associate dean, Nduati is responsible for the strategic development and growth of UCR Health, the medical schools clinical enterprise, and serves as the physician executive leader of the medical schools faculty practice.

The NMQFs 40 Under 40 List seeks to recognize leaders that are taking strides to improve and diversify the healthcare marketplace. In addition to these qualities, the NMQF looks for leaders that can be role models for the next generation of leaders in minority health. Nduati is being recognized for his leadership role in this community as a minority health leader.

Nduati started his education here at UCR with a bachelors degree in biomedical science. From here, he went to UCLA to earn his M.D. and M.B.A. After graduating from UCLA, he interned and did his residency at Kaiser Permanente Fontana. Then, he continued onto Harvard to earn his Masters in Public Health.

NMQF assists health-care providers, professionals, administrators, researchers, policy makers and community and faith-based organizations to create better programs for their communities to eliminate premature death and preventable illnesses.

The recipients of the 40-Under-40 List will receive their awards on April 25, 2017 at the 2017 NMQF Leadership Summit of Health Disparities and Congressional Black Caucus Spring Health Braintrust Gala Dinner in Washington, D.C.

Original post:
News in brief - Highlander Newspaper

12th Annual Wisconsin Stem Cell Symposium to focus on bioengineering – University of Wisconsin-Madison

Over the past several years, gene editing has become a powerful tool for creating cellular models of human diseases, particularly with the emergence of technologies like CRISPR-Cas9.

But one concern with gene editing tools like CRISPR which allows scientists to cut and paste genetic sequences into a genome to correct errors or introduce changes is precision, says Krishanu Saha, a bioengineering professor at the University of WisconsinMadison. That is, editing genes sometimes introduces errors that could have unintended consequences.

Saha is using CRISPR to reprogram human pluripotent stem cells and immune cells to study diseases like Fragile X syndrome, to discover new drugs and develop cell therapies, and to ask fundamental questions about human biology. On Wednesday, April 19, he will present the strategies his lab has developed to make gene editing more precise at the 12th Annual Wisconsin Stem Cell Symposium.

My talk is focused on genome-level engineering of human cells, Saha says. I will cover ongoing work in my lab that engineers human pluripotent stem cells and T cells from cancer patients.

The strategies Saha and his research team have developed help correct pathogenic point mutations and introduce transgenes with precision, reducing and in some cases eliminating undesirable genomic effects.

Another UWMadison scientist, Professor of Chemical and Biological Engineering Eric Shusta, is using stem cells to explore the biology of the blood-brain barrier. This work will be the subject of his talk at the symposium, which is hosted by the UWMadison Stem Cell and Regenerative Medicine Center (SCRMC) and the BioPharmaceutical Technology Center Institute (BTCI).

The blood-brain barrier is an impermeable network of endothelial cells that protects the brain from toxins and other potentially harmful agents that may be circulating in the blood. A healthy blood-brain barrier is essential for well-being, but issues with this security system for the brain can lead to developmental or other types of disease.

Using stem cells, Shusta and his colleagues have been able to reconstruct the blood-brain barrier in the laboratory dish, providing scientists with a potent model for drug discovery and to explore neurological disorders that may be associated with a compromised barrier. The advent of patient-sourced induced pluripotent stem cells means it may be possible to mimic diseases or conditions and possibly devise treatments for disorders that are now untreatable.

The symposium will also gather a handful of national and international speakers, like Memorial Sloan Kettering Cancer Centers Michel Sadelain (New York) and Leiden University Medical Centers Christine Mummery (The Netherlands), focused around the theme: Engineering Cells and Tissues for Discovery and Therapy.

We sought to bring bioengineers together with biologists and clinicians this year, says Saha, who is also a co-organizer of the event with UWMadison Professor of Chemical and Biological Engineering Sean Palecek. Because bioengineers are working at many levels the genome, cell and tissue we have invited scientists across these scales.

Talks will focus on emerging strategies to control stem cell behavior in the lab and in the body and include genome and cell engineering; stem cells as models of cell and developmental biology; in vitro maturation of stem-cell derived tissues; tissue engineering and organoid development; biomanufacturing; and treatments utilizing engineered human cell products.

We see great synergy in bringing together techniques of controlling behavior across these scales to generate new research tools and therapeutics, Saha says.

Moderators of the symposium include Timothy Kamp, professor of medicine and co-director of SCRMC ; William Murphy, professor of biomedical engineering, orthopedics and rehabilitation, and co-director of SCRMC; Saha and Palecek. It takes place from 8:30 a.m. until 6 p.m. at the BioPharmaceutical Technology Center, 5445 E. Cheryl Parkway, Fitchburg, Wisconsin 53711.

See the rest here:
12th Annual Wisconsin Stem Cell Symposium to focus on bioengineering - University of Wisconsin-Madison

Stanford Existential Risk Initiative tackles global threats – The Stanford Daily

Stanford launched the official Stanford Existential Risk Initiative (SERI) on Friday, which aims to foster engagement from students and professors to produce meaningful work aiming to preserve the future of humanity. Specifically, its goal is to prevent global catastrophic risks (GCRs) risks that threaten to destroy human civilization or drive the entire species extinct.

The organizations current plans include hosting a speaker series of prominent people in the world of GCR-mitigation, such as Precipice author Toby Ord, as well as offering $7,500 stipends for undergraduate summer projects. Funding for between 10 and 20 projects will be provided by Open Philanthropy. And during the academic year, SERI hopes to integrate its offerings into the brand-new Catastrophic Risks and Solutions (CRS) concentration in the Science, Technology and Society (STS) major.

SERI, hosted under the Freeman Spogli Institute for International Studies, is the product of an alliance between the STS program, the Center for International Security and Cooperation (CISAC), Stanford Global Health and the existing local effective altruism community. Its co-leaders are professor Stephen Luby in the School of Medicine and professor Paul Edwards, the director of the STS program.

Luby and Edwards met over shared interest in teaching a course on human extinction at Stanford. That course, THINK 65: Preventing Human Extinction, is now in its second year and has about 100 students.

Edwards told The Daily that Luby reached out to him with the original idea for the class.

Right after I was hired at Stanford before anything had happened and while I was still in Ann Arbor Steve wrote me and said, Do you want to teach a course on preventing human extinction? Edwards said. And I had never met him, I knew nothing about him, I saw this email and immediately said, Yes. I have been working on climate change for the past 30 years, and before I worked on climate change I mainly worked on the role of computers in nuclear war.

Climate change and nuclear war are two of the four focuses of the class; the others are uncontrollable artificial intelligence and, of course, plague natural or artificial.

Luby described the possibility of human-caused extinction as a new phenomenon in his lifetime.

I dont think we got to the point where humans could destroy civilization until the advent of nuclear arsenals, he said.

But the course has not treated COVID-19 as a global catastrophic risk. Luby, an expert epidemiologist who spent time at the Centers for Disease Control and Prevention (CDC), said that the kind of worst-case scenarios the course describes short of extinction are things that would cause us to lose all our scientific understanding, all our art, and where humanity is reduced to being largely illiterate: things with no hope of recovery. COVID-19 is unlikely to alter the long-term trajectory of mankind.

The course discusses the novel coronavirus in the context of previous disasters of even larger scales the bubonic plague, which shut down the Silk Road and emptied entire cities in Europe in the Late Middle Ages, or the Old World epidemics that ravaged New World civilizations and tribes post-contact.

We taught that course last spring for the first time, and we were surprised that it generated so much interest, Luby said. Then someone at Effective Altruism, maybe Kuhan, reached out to us and Open Philanthropy reached out to me and as part of that conversation we thought about how we could help build skills and capacities for students who are interested in taking global catastrophic risk seriously.

Effective altruism is a philosophy that focuses on doing good based on evidence rather than intuition or tradition. It also emphasizes diverting college students toward high-impact careers to fight challenges such as runaway climate change in the current century.

Kuhan Jeyapragasan 20 M.S. 20, the president of student group Stanford Effective Altruism, is a student collaborator in SERI who linked Luby and Edwards to Open Philanthropy funding. He described the issues of civilization collapse and mankinds extinction as a natural extension of general effective altruism thought.

A lot of effective altruists are focused on making sure the future goes well, and going along with that is the idea of preventing really bad catastrophes that would either cause extinction or the permanent downfall of civilization, Jeyapragasan said.

Jeyapragasan, who has led some work for the summer program, designed the project to immerse ambitious students in a full-time network of people and ideas. To apply, students had to find a mentor and compose a project proposal. Jeyapragasan described being blown away by scores of detailed applications and technical project ideas, focused on issues such as nuclear policy and bioengineering and, most of all, climate change.

Accepting all proposals would require millions of dollars, which is beyond SERIs reach. But interested students unable to secure summer funding can still participate in SERI through part-time projects or its upcoming speaker series, which will include mentors from the summer program as well as Stanford professors focused on issues such as climate change. SERI also hopes to develop relationships with similar groups at other universities, such as the Nuclear Threat Initiative at MIT, headed by former secretary of energy Ernest Moniz.

The question of nuclear destruction is the original spark for all modern extinction-prevention efforts, even as the number of ways humanity might destroy itself has ballooned.

SERI is Stanfords newest answer to the question of extinction. Future speaker events, virtual or in person, will be publicized through Stanford mailing lists and interest groups.

Jeyapragasan said that SERI is not an outlet for pessimistic prognosticators, but for hopeful optimists.

If you look at how humanity has progressed in terms of alleviating poverty and on social issues, education, all these other fronts, weve done a pretty miraculous job, Jeyapragasan said. And I think we will continue to find solutions and that the future will be really great the problems we face today, like climate change, we can solve. And eventually we might eradicate existential risk, or at least anthropogenic existential risk.

Contact Cooper Veit at cveit at stanford.edu.

The rest is here:
Stanford Existential Risk Initiative tackles global threats - The Stanford Daily

ABI researchers to develop a more personalised approach to ventilator monitoring – New Zealand Doctor Online

Ventilators save lives, but treating patients with mechanical ventilators is not without risk.

Dr Haribalan Kumar, Auckland Bioengineering Institute (ABI), University of Auckland, plans to reduce that risk with a technology that will allow for more precise and dynamic monitoring of lung function at the bedside of a patient being treated with a ventilator. He and his team have received $150,000 from the Health Research Councils Explorer Fund to do so.

A ventilator takes over the bodys breathing process when the lung begins to fail as it does when a patient has lung disease such as pneumonia, which has affected many Covid-19 patients. This gives patients time to recover from their condition.

However, mechanical ventilation involves using high pressures to pump oxygen into the tiny air sacs of the lung, which can save peoples lives but also cause lung injury, particularly if a patient requires long term treatment.

The monitoring of lung function (and adjusting the ventilators in response) is crucial to avoiding ventilator-related injury, particularly in critical care patients.

Such patients need bedside monitoring, but this is currently limited to measurements taken externally: pressure, volume and blood gases. This makes it very difficult for clinicians to track how a patient is responding with any precision, says Dr Kumar.

It means they can only respond to significant changes in a patient; without more precise monitoring, the greater the risk to the adverse effects of mechanical ventilation, which can affect the patient for life.

Building upon New Zealands reputation in modelling lung physiology and working with international collaborators, he and his team (including Professor Merryn Tawhai and Dr Alys Clark) hope to resolve this issue by combining patient-specific models of the lung with low-cost dynamic imaging.

Electrical Impedance Tomography (or EIT) is a technology that allows for imaging of the lungs inside the chest wall, by measuring signals from a belt of electrodes placed around the chest. EIT offers an imaging solution for continuous monitoring but EIT has not been taken up widely because it has much lower resolution than other established imaging methods and it can be difficult to interpret, says Dr Kumar.

He points out that differences in individual physiology (age, size, height, underlying health conditions etc.) mean that one lung is not like another, and this complicates the translation of measurements into a meaningful image.

Dr Kumars approach, if successful, will personalise the imaging information and improve its clinical value. We hope our research will transform EIT from a potentially useful but difficult to interpret technology, to one that is personalised and easy for clinicians to use and interpret, says Dr Kumar.

The rest is here:
ABI researchers to develop a more personalised approach to ventilator monitoring - New Zealand Doctor Online